Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brain Health in Transgender Adults

NCT: NCT07624747 · RECRUITING

NCT IDNCT07624747
StatusRECRUITING
Start Date2025-10-14
Completion2028-04
SponsorUniversity of Wisconsin, Madison (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to test whether and how a person's brain changes in the first few months after starting gender affirming hormone therapy (GAHT). The investigators want to know if GAHT changes: 1) cerebral blood flow (CBF), 2) brain structure, connectivity, and cognitive task performance, and 3) neurocognitive function (memory, attention, executive function, processing speed). 36 male at birth and 36 female at birth participants will conduct baseline studies prior to GAHT, with a second identical set of study visits 4-6 months after GAHT begins.

Frequently Asked Questions

What is Brain Health in Transgender Adults?

Brain Health in Transgender Adults is a clinical trial registered under NCT07624747. Current status: RECRUITING.

What is the status of NCT07624747?

The current status of NCT07624747 (Brain Health in Transgender Adults) is: RECRUITING.

When did Brain Health in Transgender Adults start?

Brain Health in Transgender Adults started on 2025-10-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.